Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1874-1888
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1874
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1874
Complication/stage observed | Dysbiosis observed | |
Decreased | Increased | |
Diabetic nephropathy | Lactobacillus, Bifidobacterium, Bacteroides, Prevotella, Roseburia, Ruminococcaceae, and Faecalibacterium | Enterococcus, Enterobacteriaceae, Clostridaceae, Klebsiella, and Parabacterides |
Diabetic neuropathy | Bacteroides and Faecalibacterium | Escherichia, Blautia, Ruminococcus torques, and Lachnoclostridium |
Diabetic retinopathy | Bacteroidetes and Actinobacteria | Escherihia, Enterobacter, and Acidaminococcus |
Cerebrovascular disease | Lachnospiraceae, Ruminococcaceae, Bacteroidetes, Prevotella, and Faecalibacterium | Enterobacteriaceae, Veillonellaceae, Bifidobacterium, Lactobacillus, and Oscillobacter |
Cardiovascular disease | Roseburia, Eubacterium spp, Bacteroides and Faecalibacterium | Collinsella, Escherichia-Shigella, Enterococcus, and the ratio of Firmicutes to Bacteroides |
Peripheral vascular disease | - | Firmicutes, Actinobacteria, Verrucomicrobia, and Proteobacteria |
- Citation: Jeyaraman M, Mariappan T, Jeyaraman N, Muthu S, Ramasubramanian S, Santos GS, da Fonseca LF, Lana JF. Gut microbiome: A revolution in type II diabetes mellitus. World J Diabetes 2024; 15(9): 1874-1888
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1874.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1874